Clinical Impact of the IBox As an Early Intervention TooL

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 507 participants.

Also called NCT05112315

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 507 participants (enrolled count) (from the registry)
Sponsor
Predict4Health (from the registry)
Registry
  • NCT NCT05112315
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Austria, France, Germany, Israel, Spain, United Kingdom (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05112315. Randomized; no masking; primary purpose prevention. Start 2022-02-18 (actual); primary completion 2025-02 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Impact of the IBox As an Early Intervention TooL
Condition
Kidney Diseases
Condition
Kidney Disease, Chronic
Condition
Kidney Transplant Rejection
Condition
Kidney Transplant; Complications
Condition
Kidney Failure
Condition
Kidney Failure, Chronic
Condition
Kidney Dysfunction
Intervention (Device)
Predigraft
Lead sponsor
Predict4Health (class: industry)

Record details

Record id
cardio:ct-nct05112315
Content hash
3639ee55e8613a96e8d8296c6279560b08e47177a10d8f4901f454600a053ded